Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits
Abstract Although cardiac troponin is a highly specific biomarker for myocardial cell injury, it is important to recognize the pitfalls of this test in the diagnosis and management of immune checkpoint inhibitor (ICI) myocarditis. We describe the challenging case of an 81‐year‐old woman with persist...
Saved in:
Main Authors: | Mizuki Ida, Shiro Nakamori, Shinya Yamamoto, Seimi Watanabe, Kyoko Imanaka‐Yoshida, Masaki Ishida, Hajime Sakuma, Keiichi Yamanaka, Kaoru Dohi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13915 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
by: Daniel Kiblboeck, et al.
Published: (2022-06-01) -
Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01) -
“Smouldering conditions of the shoulder” Lest we forget!
by: Anupam Wakhlu, et al.
Published: (2017-01-01) -
A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Naoya Nakashima, et al.
Published: (2022-06-01) -
Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)